3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Burkitt Lymphoma
1
Interventions
Paclitaxel
22
Carboplatin
18
liposomal doxorubicin
14
Bevacizumab
9
Topotecan
8
Docetaxel
8
Gemcitabine
7
Cisplatin
7
rucaparib
6
pembrolizumab
6
mirvetuximab soravtansine
5
Cyclophosphamide
5
Taxes
4
Albumin-Bound Paclitaxel
4
sargramostim
3
ixabepilone
3
Cytoreduction Surgical Procedures
3
CCV-AV protocol
3
130-nm albumin-bound paclitaxel
3
taxane
2
talazoparib
2
pazopanib
2
olaparib
2
fludarabine phosphate
2
fludarabine
2
denileukin diftitox
2
cediranib
2
catumaxomab
2
belinostat
2
avelumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Ovarian Epithelial
×
Laparotomy
×
Clear all
NCT00008138
2016-01-08
S0009
SWOG Cancer Research Network
Phase 2
Completed
62 enrolled
9 charts